ALNYLAM PHARMACEUTICALS, INC. financial data

Symbol
ALNY on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 276% % -5%
Quick Ratio 5.5% % -28%
Debt-to-equity 1239% %
Return On Equity 90% % -90%
Return On Assets 6.8% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 132,623,144 shares 2.4%
Common Stock, Shares, Outstanding 132,376,000 shares 2.4%
Entity Public Float $42,630,000,000 USD 38%
Common Stock, Value, Issued $1,324,000 USD 2.4%
Weighted Average Number of Shares Outstanding, Basic 131,004,000 shares 2.6%
Weighted Average Number of Shares Outstanding, Diluted 134,684,000 shares 5.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $3,713,937,000 USD 65%
Research and Development Expense $1,319,775,000 USD 17%
Costs and Expenses $3,212,359,000 USD 32%
Operating Income (Loss) $501,578,000 USD
Nonoperating Income (Expense) $178,426,000 USD 11%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $323,152,000 USD
Income Tax Expense (Benefit) $9,405,000 USD 77%
Net Income (Loss) Attributable to Parent $313,747,000 USD
Earnings Per Share, Basic 2.39 USD/shares
Earnings Per Share, Diluted 2.33 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,657,250,000 USD 71%
Accounts Receivable, after Allowance for Credit Loss, Current $777,567,000 USD 92%
Inventory, Net $82,719,000 USD 5.4%
Assets, Current $4,050,662,000 USD 23%
Deferred Income Tax Assets, Net $125,975,000 USD 7.8%
Property, Plant and Equipment, Net $513,147,000 USD 2.1%
Operating Lease, Right-of-Use Asset $194,916,000 USD 2%
Other Assets, Noncurrent $59,461,000 USD -9%
Assets $4,966,331,000 USD 17%
Accounts Payable, Current $115,721,000 USD 31%
Employee-related Liabilities, Current $257,197,000 USD 20%
Accrued Liabilities, Current $1,080,197,000 USD 36%
Contract with Customer, Liability, Current $4,845,000 USD -91%
Liabilities, Current $1,466,349,000 USD 24%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $225,087,000 USD -1.9%
Other Liabilities, Noncurrent $7,594,000 USD 53%
Liabilities $4,177,155,000 USD 0.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $20,097,000 USD 42%
Retained Earnings (Accumulated Deficit) $6,702,524,000 USD 8%
Stockholders' Equity Attributable to Parent $789,176,000 USD 1076%
Liabilities and Equity $4,966,331,000 USD 17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $118,314,000 USD -45%
Net Cash Provided by (Used in) Financing Activities $44,084,000 USD 52%
Net Cash Provided by (Used in) Investing Activities $113,769,000 USD
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 132,376,000 shares 2.4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $53,597,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,658,807,000 USD 71%
Interest Paid, Excluding Capitalized Interest, Operating Activities $66,933,000 USD 116%
Deferred Tax Assets, Valuation Allowance $2,732,329,000 USD -2%
Deferred Tax Assets, Gross $2,917,483,000 USD -1.7%
Operating Lease, Liability $270,605,000 USD -0.3%
Payments to Acquire Property, Plant, and Equipment $8,970,000 USD -31%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $328,168,000 USD
Lessee, Operating Lease, Liability, to be Paid $366,276,000 USD -4.7%
Property, Plant and Equipment, Gross $835,847,000 USD 8.1%
Operating Lease, Liability, Current $45,518,000 USD 8.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $52,747,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year One $48,073,000 USD 11%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) $9,639,000 USD 2023%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $95,671,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Three $44,308,000 USD 6.5%
Deferred Tax Assets, Operating Loss Carryforwards $987,117,000 USD 12%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $77,969,000 USD 31%
Lessee, Operating Lease, Liability, to be Paid, Year Four $42,990,000 USD 6.1%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $348,235,000 USD 28%
Interest Expense $127,519,000 USD -11%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%